Prochlorperazine Edisylate Injection
NDC Package 55150-360-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Prochlorperazine Edisylate injection is to control severe nausea and vomiting. This formulation utilizes a injection delivery system. Marketed by Eugia Us Llc, this product is identified by NDC 55150-360 and is authorized under FDA application ANDA213873.

Identification & Billing

NDC Package Code
55150-360-01
Package Description
1 VIAL, MULTI-DOSE in 1 CARTON / 2 mL in 1 VIAL, MULTI-DOSE
Product Code
55150-360
11-Digit Billing Format
55150036001
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Prochlorperazine Edisylate
Non-Proprietary Name
Prochlorperazine Edisylate
Substance Name
Prochlorperazine Edisylate
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
PROCHLORPERAZINE EDISYLATE 5 mg/mL
Pharmacologic Class
Usage Information
To control severe nausea and vomiting. For the treatment of schizophrenia. Prochlorperazine has not been shown effective in the management of behavioral complications in patients with mental retardation.

Regulatory & Marketing

Labeler Name
Eugia Us Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA213873
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-14-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (55150-360). Click a package code to view its specific billing and regulatory data.

55150-360-25
25 VIAL, MULTI-DOSE in 1 CARTON / 2 mL in 1 VIAL, MULTI-DOSE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55150-360-01 identifies a specific commercial package of 1 vial, multi-dose in 1 carton / 2 ml in 1 vial, multi-dose of Prochlorperazine Edisylate, a human prescription drug labeled by Eugia Us Llc. This injection is formulated for intramuscular; intravenous use and contains prochlorperazine edisylate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Eugia Us Llc on July 14, 2022. The current certification is valid through December 31, 2026.

How is this Eugia Us Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55150036001. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55150-360-01
11-Digit CMS (5-4-2)
55150-0360-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.